Home / Pipeline / Tazarotene Lotion, 0.1% + Tazarotene Cream, 0.1% Products Tazarotene Lotion, 0.1% + Tazarotene Cream, 0.1%
Tazarotene Lotion, 0.1% + Tazarotene Cream, 0.1% Phase 2 Completed 💤 Quiet Interest: 32/100
Oct 4, 2017 → Apr 30, 2018
About Tazarotene Lotion, 0.1% + Tazarotene Cream, 0.1% Tazarotene Lotion, 0.1% + Tazarotene Cream, 0.1% is a phase 2 stage product being developed by Dr. Reddy's Laboratories for Acne Vulgaris. The current trial status is completed. This product is registered under clinical trial identifier NCT03599193. Target conditions include Acne Vulgaris.
What happened to similar drugs? 20 of 20 similar drugs in Acne Vulgaris were approved
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT03599193 Phase 2 Completed Oct 4, 2017 Apr 30, 2018 Acne Vulgaris
Product Company Stage Hype Score DFD-03 Dr. Reddy's Laboratories Phase 3 DFD-03 Lotion, 0.1% + Tazorac Cream, 0.1% + DFD-03 Vehicle Lotion 0% + Tazorac Vehicle Cream 0% Dr. Reddy's Laboratories Phase 2 DFD-03 (0.1% tazarotene) Lotion + DFD-03 (0% tazarotene) Lotion (Placebo) Dr. Reddy's Laboratories Phase 3 Olumacostat Glasaretil Gel, 5.0% Eli Lilly Phase 3 HT-001 2% Topical Gel + HT-001 1% Topical Gel + HT-001 0.5% Topical Gel + HT-001 Placebo Hoth Therapeutics Phase 2 Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + Placebo Sun Pharmaceutical Phase 1 Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control Sun Pharmaceutical Phase 1 Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test product Sun Pharmaceutical Phase 1 Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical Gel Sun Pharmaceutical Phase 1 Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma) Sun Pharmaceutical Phase 1 Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories) Sun Pharmaceutical Phase 1 Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + Placebo Sun Pharmaceutical Phase 1 ADPS topical product + Placebo Control Sun Pharmaceutical Phase 2 Isotretinoin Sun Pharmaceutical Approved Winlevi (Clascoterone) cream 1% Sun Pharmaceutical Approved Adapalene Gel 0.3% + Differin® + Placebo Sun Pharmaceutical Phase 1 CLPG Topical Gel 1% + Clindamycin + Placebo Sun Pharmaceutical Phase 1 Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + Placebo Sun Pharmaceutical Phase 1 Test. + Aczone Gel 5% + Placebo Sun Pharmaceutical Phase 1 Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + Placebo Sun Pharmaceutical Phase 1